125 related articles for article (PubMed ID: 20156584)
1. Gangliosides influence EGFR/ErbB2 heterodimer stability but they do not modify EGF-dependent ErbB2 phosphorylation.
Milani S; Sottocornola E; Zava S; Galbiati M; Berra B; Colombo I
Biochim Biophys Acta; 2010 Jun; 1801(6):617-24. PubMed ID: 20156584
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM(3) is stably associated to tyrosine-phosphorylated ErbB2/EGFR receptor complexes and EGFR monomers, but not to ErbB2.
Milani S; Sottocornola E; Zava S; Berselli P; Berra B; Colombo I
Biochim Biophys Acta; 2007 Jul; 1771(7):873-8. PubMed ID: 17521961
[TBL] [Abstract][Full Text] [Related]
3. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
Sottocornola E; Berra B; Colombo I
Biochim Biophys Acta; 2003 Dec; 1635(2-3):55-66. PubMed ID: 14729068
[TBL] [Abstract][Full Text] [Related]
4. Role of gangliosides in the association of ErbB2 with lipid rafts in mammary epithelial HC11 cells.
Sottocornola E; Misasi R; Mattei V; Ciarlo L; Gradini R; Garofalo T; Berra B; Colombo I; Sorice M
FEBS J; 2006 Apr; 273(8):1821-30. PubMed ID: 16623716
[TBL] [Abstract][Full Text] [Related]
5. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
[TBL] [Abstract][Full Text] [Related]
6. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
Wang Z; Zhang L; Yeung TK; Chen X
Mol Biol Cell; 1999 May; 10(5):1621-36. PubMed ID: 10233167
[TBL] [Abstract][Full Text] [Related]
7. Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors.
Kim SM; Jung JU; Ryu JS; Jin JW; Yang HJ; Ko K; You HK; Jung KY; Choo YK
Biochem Biophys Res Commun; 2008 Jul; 371(4):866-71. PubMed ID: 18471991
[TBL] [Abstract][Full Text] [Related]
8. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
Pagano E; Calvo JC
J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
[TBL] [Abstract][Full Text] [Related]
9. Role of ErbB2 in Corneal Epithelial Wound Healing.
Xu KP; Riggs A; Ding Y; Yu FS
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4277-83. PubMed ID: 15557433
[TBL] [Abstract][Full Text] [Related]
10. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1A and GT1B.
Mirkin BL; Clark SH; Zhang C
Cell Prolif; 2002 Apr; 35(2):105-15. PubMed ID: 11952645
[TBL] [Abstract][Full Text] [Related]
12. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
[TBL] [Abstract][Full Text] [Related]
13. Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2.
Gulliford TJ; Huang GC; Ouyang X; Epstein RJ
Oncogene; 1997 Oct; 15(18):2219-23. PubMed ID: 9393980
[TBL] [Abstract][Full Text] [Related]
14. Membrane distribution of epidermal growth factor receptors in cells expressing different gangliosides.
Zurita AR; Crespo PM; Koritschoner NP; Daniotti JL
Eur J Biochem; 2004 Jun; 271(12):2428-37. PubMed ID: 15182358
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
16. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
17. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
Liu Y; Li R; Ladisch S
J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
[TBL] [Abstract][Full Text] [Related]
18. The emergence of ErbB2 expression in cultured rat hepatocytes correlates with enhanced and diversified EGF-mediated signaling.
Scheving LA; Zhang L; Stevenson MC; Kwak ES; Russell WE
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G16-25. PubMed ID: 16769812
[TBL] [Abstract][Full Text] [Related]
19. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization.
Li Y; Macdonald-Obermann J; Westfall C; Piwnica-Worms D; Pike LJ
J Biol Chem; 2012 Sep; 287(37):31116-25. PubMed ID: 22822073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
